Lallemand Health Solutions will meet and greet industry partners at the coming Vitafoods Europe in Geneva, May 5-7, 2015. During this event, the leading developer and provider of tailored probiotics solutions will introduce an extended range of probiotic strains to address targeted segments of the immunity market: children, adults, and seniors. This will be the occasion to present its latest clinical and in vitro results on the impact of selected probiotics on the immune response. Lallemand's Women’s Health offer will also be highlighted through an oral presentation. Additionally, the company will introduce you to its full line of ready-to-market probiotic formula and strains for custom formulations in other areas such as gut health, emotional equilibrium or oral health.
Today, the interactions between probiotics and immunity are increasingly well understood. Thanks to a strong R&D program dedicated to immunity, encompassing innovative in vitro, in vivo and clinical studies, scientists at Lallemand Health Solutions are now able to draw a better picture of the pathways involved and the clear benefits of selected probiotic strains and strains combinations. On this basis, Lallemand has been able to design a portfolio of probiotic strains and strains combinations to address various issues of immune health for different target population groups related to: children, at-risk adults (under chronic stress, athletes), immunity in seniors susceptible to lower immune response (“inflammaging”). These strains can be formulated into specific solutions, associated to certain vitamins or minerals for example, in formats adapted to each target population: capsules, convenient orodispersible sticks, sachets to dissolve in drinks or food etc.
Meet Lallemand at booth J80 and work together to develop the best suited formulation for your market.